Research / OTEX / Fundamental state Inspectable configuration
State dimensions Filing 0001002638-22-000022 General Corporate
Debt relative to revenue 67th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.debt_to_revenue
478.37% · OPTIONAL · VALID
Capex intensity 56th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.99% · OPTIONAL · VALID
Operating cash generation 89th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
36.67% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
5.93% · CORE · NOT_ENOUGH_HISTORY
Gross margin 33th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.gross_margin
68.92% · CORE · VALID
Operating margin 11th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.operating_margin
14.92% · CORE · VALID
SBC intensity 100th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.90% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 27 states Self-history eligible
Sep 30, 2021 0/7 normalized Level 3 Dec 31, 2021 6/7 normalized Level 3 Mar 31, 2022 6/7 normalized Level 3 Jun 30, 2022 6/7 normalized Level 3 Sep 30, 2022 6/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 481.47%
Current 478.37%
Delta -3.10% Capex Intensity Increased
Previous 1.21%
Current 1.99%
Delta 0.78% Cash Generation Increased
Previous 24.71%
Current 36.67%
Delta 11.96% Growth Increased
Previous 2.47%
Current 5.93%
Delta 3.45% Margin Decreased
Previous 70.21%
Current 68.92%
Delta -1.29% Profitability Decreased
Previous 22.00%
Current 14.92%
Delta -7.08% Sbc Intensity Increased
Previous 1.64%
Current 1.90%
Delta 0.25% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.